- Home
- LDWY vs COSM Comparison
LDWY vs COSM Comparison
Compare LDWY & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- COSM
- Stock Information
- Founded
- LDWY 1990
- COSM 2009
- Country
- LDWY United States
- COSM Greece
- Employees
- LDWY N/A
- COSM N/A
- Industry
- LDWY Advertising
- COSM Other Pharmaceuticals
- Sector
- LDWY Consumer Discretionary
- COSM Health Care
- Exchange
- LDWY Nasdaq
- COSM Nasdaq
- Market Cap
- LDWY 6.9M
- COSM 8.2M
- IPO Year
- LDWY 1991
- COSM 2013
- Fundamental
- Price
- LDWY $4.27
- COSM $0.45
- Analyst Decision
- LDWY
- COSM
- Analyst Count
- LDWY 0
- COSM 0
- Target Price
- LDWY N/A
- COSM N/A
- AVG Volume (30 Days)
- LDWY 6.2K
- COSM 814.2K
- Earning Date
- LDWY 05-13-2025
- COSM 05-15-2025
- Dividend Yield
- LDWY N/A
- COSM N/A
- EPS Growth
- LDWY N/A
- COSM N/A
- EPS
- LDWY N/A
- COSM N/A
- Revenue
- LDWY $42,183,000.00
- COSM $54,426,402.00
- Revenue This Year
- LDWY N/A
- COSM $28.14
- Revenue Next Year
- LDWY N/A
- COSM N/A
- P/E Ratio
- LDWY N/A
- COSM N/A
- Revenue Growth
- LDWY 425.12
- COSM 1.97
- 52 Week Low
- LDWY $3.02
- COSM $0.28
- 52 Week High
- LDWY $5.88
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- LDWY 62.01
- COSM 53.31
- Support Level
- LDWY $3.83
- COSM $0.40
- Resistance Level
- LDWY $4.00
- COSM $0.50
- Average True Range (ATR)
- LDWY 0.19
- COSM 0.06
- MACD
- LDWY 0.03
- COSM 0.01
- Stochastic Oscillator
- LDWY 66.62
- COSM 46.91
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.